|
Print this Page
Get Involved...
|
|
|
Program Summary
|
| Title: | TA2 - ADHD and Autism Spectrum Disorder: New Data/New Ideas |
| Program Code: | TA2 |
| When: | Thursday @ 09:00 AM |
| Speaker(s): |
Sam Goldstein Ph.D.
|
| Co-Speaker(s): |
|
| Description: | LECTURE
[Psychologist]
[Healthcare]
[Educator]
ADHD and Autism Spectrum Disorder: New Data and New Ideas
It has increasingly become apparent to educators, researchers and clinicians alike that symptom relief for ADHD does not necessarily nor significantly transfer to improving long-term outcome in the areas of school, vocation, relationships, mental health and general community issues. By far the bulk of ADHD related research has been focused on the benefits of symptom relief over a short term period. Very few studies follow children for six months to a year, let alone ten years. As more and more data assessing long-term outcome is being generated, it has become apparent that the treatment protocol for ADHD needs to provide a balanced focus between interventions that improve immediate symptoms and functioning with those that facilitate generalization and adequacy of functioning through adolescence to transition into the adult years. In this presentation, Dr. Goldstein will provide an overview of current research in two major domains. First, research concerning the effectiveness of treatments for ADHD, on both a symptom relief and long-term outcome basis will be presented. Second, a review of the resilience literature focusing on a variety of environmental, biological and experiential variables that appear to improve adult outcome in youth with histories of neurodevelopmental weaknesses will be offered. Dr. Goldstein will provide suggestions for a new treatment protocol for ADHD, focusing on a balance between symptom relief and improving long-term outcome in school, home and community.
|
| Learning Objectives: | ADHD and Autism Spectrum Disorder: New Data and New Ideas:
1. Participants will understand current theories about treatments for ADHD and their impact upon symptom relief.
2. Participants will understand the longitudinal research in regards to outcome variables for ADHD.
3. Participants will understand general environmental and developmental variables that predict good life outcome for all children as well as those with neurodevelopmental weaknesses.
4.Participants will be provided with an overview of a new treatment protocol for ADHD.
5. Participants will be provided with specific strategies to begin implementing this treatment protocol in their clinical practices and educational settings.
|
Go Back
|
|
